To see, to know, to heal .    

Declare the past,
diagnose the present,
foretell the future (Hippocrates)

Seeing is the
beginning

Milestones
Research
About us
Career

photonamic

The name photonamic consists of photo (= light) and dynamics and thus represents the field of activity of photonamic GmbH & Co. KG ("photonamic"). The effect of light on certain molecules is manifold and ultimately leads not only to coloration, but can also lead to fluorescence or initiation of chemical reactions.
Photonamic takes advantage of these dynamics of light by using a specific molecule that is metabolized into a photosensitizer in cells or in cell assemblies or in the body. Depending on the choice of wavelength, this can lead to a wide variety of effects triggered by the light. The use of light and the application of photosensitizers is not really a new principle, but has been known and researched for decades.
photonamic has set itself the goal of researching and developing these possibilities in a targeted manner in order to derive diverse applications from them. Unlike many other approaches, the molecule primarily used by photonamic is a precursor of the actual photosensitizer, which is metabolically converted into the light-excitable molecule and exhibits the corresponding photodyna-mic properties. The resulting fascinating applications in imaging and also therapy form the core of photonamic's activities.
Through numerous collaborations and projects with partner companies, academic institutions for clinical applicability and also with corresponding equipment companies for light sources, sensors and camera systems, the diversity of these technologies can be imagined.

‍

TOP STORIES

‍

‍"NX Development Corp. ls Granted Orphan Drug Designation Status by US FDA for Gleolan® in Ovarian and Related Cancers"

‍

‍

Lexington, KY, March 5, 2024 -NX Development Corp. (NXDC) has achieved another
milestone as we proudly announce the recent granting of orphan-drug status by the U.S. Food
and Drug Administration (FDA) for Gleolan (aminolevulinic acid HCl). This designation was
provided for the "real-time detection and visualization of epithelial ovarian tumors during
debulking surgery."
Dr. Salvatore DeSena, CEO of NX Development Corp., shared this excitement, stating, "On
behalf of our entire team, I am proud to announce that NX Development Corp. secured orphan-
drug status for Gleolan in ovarian, fallopian tube, and primary peritoneal cancer. This
achievement demonstrates NXDC's commitment to exploring new and innovative uses for
Gleolan to help patients and surgeons in their fight against these cancers.

"This important milestone underlines the capabilities of aminolevulinic acid HCl in fluorescence-
guided surgery. As a group we aim to expand this further, also to other countries as well,
providing support to patients and healthcare professionals combating cancer globally", said Dr.
Ulrich Kosciessa, Chairman of the Board of NXDC and CEO of photonamic GmbH & Co KG.
(Pinneberg, Germany) parent company to NXDC.

‍

....more

‍

‍

‍

NEWS ARCHIVE

photonamic GmbH & Co. KG successfully obtains ManufacturingLicense under GMP

After successful completion of planned inspections by the local health authorities,photonamic GmbH & Co. KG (photonamic), a pharmaceutical company focused on thedevelopment of 5-aminolevulinic acid (5-ALA) in various applications, was granted aManufacturing License under GMP on March 27, 2024.....

"US FDA Medical Device Registration of Aladuck405/II"

SBI Pharmaceuticals Co., Ltd. (Head office: Minato-ku, Tokyo; Representative Director & President:Yoshitaka Kitao; hereinafter "SBIP"), a subsidiary company of SBI Holdings, Inc. which conductsresearch and development pharmaceuticals, etc., utilizing 5-aminolevulinic acid (*) announces todaythat the medical light source device "Aladuck405/II" (hereafter "Aladuck") ....

SBI ALApromo GmbH Announces Registration on of 5-aminolevulinic Acid Phosphate Containing Cosmetic, Kiyomi Skin, in Saudi Arabia

SBI ALApromo GmbH, a company in the cosme8cs industry, is pleased to announce thesuccessful registra8on of its cosme8c brand, Kiyomi Skin, in Saudi Arabia. The regulatoryapproval enables SBI ALApromo ...

All press articles